First human test of new drug explores safety in people with liver problems
NCT ID NCT06674915
Summary
This early-stage study tested how a single dose of the experimental drug HRS-5965 behaves in people with and without liver problems. It involved 24 adults with kidney disease to see if liver function changes how the drug is processed in the body and to check for safety. The goal was to gather basic information to guide future research on this potential treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLEMENT MEDIATED PRIMARY OR SECONDARY GLOMERULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Suzhou University
Suzhou, Jiangsu, 215008, China
Conditions
Explore the condition pages connected to this study.